Proquazone
CAS No. 22760-18-5
Proquazone( Arthrex | Biarison | Proquazona | Proquazonum | Proquazone )
Catalog No. M24037 CAS No. 22760-18-5
Proquazone is a nonsteroidal anti-inflammatory agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 212 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 332 | In Stock |
|
| 25MG | 560 | In Stock |
|
| 50MG | 783 | In Stock |
|
| 100MG | 1079 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2167 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProquazone
-
NoteResearch use only, not for human use.
-
Brief DescriptionProquazone is a nonsteroidal anti-inflammatory agent.
-
DescriptionProquazone is a nonsteroidal anti-inflammatory agent.
-
In Vitro——
-
In Vivo——
-
SynonymsArthrex | Biarison | Proquazona | Proquazonum | Proquazone
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22760-18-5
-
Formula Weight278.36
-
Molecular FormulaC18H18N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESO=C1N(C(C)C)C2=C(C=CC(C)=C2)C(C3=CC=CC=C3)=N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
6-Hydroxygenistein
6-Hydroxygenistein is an isoflavonoid compound that can be found in Baptisia hirsuta and serves as a key precursor for the synthesis of various methylated isoflavonoids.
-
pep2-SVKI
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).
-
Naratuximab
Naratuximab emtansine is a humanized monoclonal antibody (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) that specifically targets CD37 (TSPAN26) and serves as the basis for creating an antibody-drug conjugate (ADC) compound.
Cart
sales@molnova.com